David F. Lehmann
- Pharmacology top 10%
- Pharmacology top 10%
- Epidemiology
- Molecular Biology
- Infectious Diseases
- Co-authors
- Joseph J. MedicisPanagiotis A. KonstantinopoulosRoy GuharoyNancy NewmanAdrienne SmithWilliam DarkoDongliang WangPatricia D. Franklin
- Topics
- Pharmacogenetics and Drug Metabolism (6 papers)Pharmaceutical studies and practices (5 papers)Health Systems, Economic Evaluations, Quality of Life (4 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
David F. Lehmann
33 papers receiving 441 citations
Peers
Comparison fields: 5 of 100
- Pharmacology 166
- Pharmacology 73
- Epidemiology 67
- Molecular Biology 59
- Infectious Diseases 59
Countries citing papers authored by David F. Lehmann
This map shows the geographic impact of David F. Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David F. Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David F. Lehmann more than expected).
Fields of papers citing papers by David F. Lehmann
This network shows the impact of papers produced by David F. Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David F. Lehmann. The network helps show where David F. Lehmann may publish in the future.
Co-authorship network of co-authors of David F. Lehmann
This figure shows the co-authorship network connecting the top 25 collaborators of David F. Lehmann. A scholar is included among the top collaborators of David F. Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David F. Lehmann. David F. Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 18 | |
| 4 | 7 | |
| 5 | 10 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 23 | |
| 9 | 8 | |
| 10 | 53 | |
| 11 | 17 | |
| 12 | 23 | |
| 13 | 27 | |
| 14 | 63 | |
| 15 | 4 | |
| 16 | 27 | |
| 17 | 7 | |
| 18 | 28 | |
| 19 | 4 | |
| 20 | 6 |
About David F. Lehmann
David F. Lehmann is a scholar working on Geriatrics and Gerontology, Family Practice and Pharmacology, having authored 37 papers that have together received 464 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). The work is most often cited by research in Pharmacology (166 citations), Geriatrics and Gerontology (37 citations) and Pharmacology (73 citations). David F. Lehmann has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Joseph J. Medicis, Panagiotis A. Konstantinopoulos, Roy Guharoy, Nancy Newman, Adrienne Smith, William Darko, Dongliang Wang, Patricia D. Franklin, William Eggleston and Robin L. Davis. Their work appears in journals such as Brain Research, CHEST Journal and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.